Berry Oncology
Foochow
About Berry Oncology
Berry Oncology develops medical technology intended to improve cancer prevention and tumor diagnosis. It offers genetic diagnosis solutions from early diagnosis to mid-late monitoring that can solve clinical problems in the direction of several malignant tumors, providing patients with a higher quality of life and reduced risk of cancer. The company's mission is early diagnosis and early treatment of all tumors, all patients receive precise treatment. Along with its vision to become a global icon in the field of early screening and early diagnosis of tumors and a leader in China's tumor gene testing market.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $230.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2021)
- Website: berryoncology.com
Industries & Categories
Health Care, Medical, Medical Device, Oncology
Canonical: https://fsome.com/organization/berry-oncology-87606 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.